Amy Schulman's path is unusual: she started as a litigator, became a top law-firm partner, then moved into Pfizer as general counsel before running major operating businesses there, including helping lead the $11.85 billion sale of Pfizer Nutrition to Nestlé, and she later co-founded and served as first CEO of Lyndra Therapeutics, giving her hands-on legal, operating, and founder experience before joining Polaris. She also has close ties to Singapore's health and research community, teaches leadership and corporate governance as a Senior Lecturer at Harvard Business School, and chairs the board of Alnylam, reflecting a long-standing interest in teaching and governance that goes back to childhood, when she reportedly asked for her own classroom blackboard.